Floradapt(TM) Baby Colic
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum subsp. longum Source : KABPTM 042 | 0.5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 0.5 Milliards d'UFC | Not calculated |
| Pediococcus pentosaceus Source : KABPTM 041 | 0.5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Dextrose, Vitamine E, L-Cystéine, Citrate de sodium, Ascorbate de sodium, Dioxyde de silicium, Trehalose, Maltodextrine, D-Mannitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et nourrissons | minimum: 1 year ; maximum: 3 years | 5 Gouttes | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps improve colic symptoms relief in babies/infants such as crying, fussing, or irritability. Helps to reduce crying time and frequency in colicky baby. Benefit in colic symptom for both formula and breast-fed baby. Provides benefit in crying time and frequency in 7 days. Floradapt(TM) Baby Colic is clinically proven to help provide/improve colic symptoms relief in both, formula and/or breast-fed babies/infants with colic syndrome. Floradapt(TM) Baby Colic is clinically proven as an effective therapy to colic syndrome in both, formula and/or breast-fed babies/infants and consequently helps improve the quality of life of the parents. Reduction of the total crying time in infants with colic. Helps reduce total crying time in infants with colic. Improvement in colic symptoms, impacting positively in the infant comfort and consequently in the quality of life of the parents. May benefit infants with colic syndrome by reducing daily crying time. Helps reduce the duration of crying episodes in babies/infants by providing gut comfort and colic symptoms relief. Helps improve colic symptoms relief in babies/infants such as crying, fussing, or irritability.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Product record
- Licence holder
- Kaneka Americas Holding Inc, CA, USA
- NPN or DIN-HM
- 80127842
- Status
- Active licence
- Licence date
- 6 November 2023
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80127842
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.